TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18455330

Group type: EXPERIMENTAL
Intervention: High PKA staining intensity (image analysis, continuous variable)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High PKA staining intensity (image analysis, dichotomized variable)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High PKA staining intensity (manual analysis)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High PKA staining intensity (image analysis, continuous)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High PKA staining intensity (image analysis, dichotomized)
Number of subjects: 80
Study: 16580376

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation with rhLH (150 IU daily) and rhFSH
Number of subjects: 120

Group type: COMPARATOR
Intervention: rhFSH alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation with rhLH and rhFSH
Number of subjects: 120
Study: 12513950

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10690979

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 100 mg suppositories for 21 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo suppositories for 21 days
Number of subjects: 50
Study: 9176035

Group type: EXPERIMENTAL
Intervention: L-arginine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: L-lysine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 0
Study: 8010430

Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 20
Study: 2809781

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (0.25 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (dexamethasone and placebo)
Number of subjects: 60
Study: 863813

Group type: EXPERIMENTAL
Intervention: Filtered air plus 0.75 ppm ozone (PO test)
Number of subjects: 13
Study: 31733006

Group type: EXPERIMENTAL
Intervention: Ketamine-lidocaine complex
Number of subjects: 586

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 586
Study: 31594919

Group type: EXPERIMENTAL
Intervention: Pomalidomide (4 mg daily for 21 days every 4 weeks) and dexamethasone (40 mg weekly)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Pomalidomide (4 mg daily for 21 days every 4 weeks) and dexamethasone (40 mg weekly) + cyclophosphamide (300 mg/m2 if less than minimal response after three cycles)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Pomalidomide and dexamethasone combination
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Pomalidomide and dexamethasone combination with cyclophosphamide
Number of subjects: 136
Study: 28440526

Group type: EXPERIMENTAL
Intervention: Three-stitch transverse colostomy (observation group, n=35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional transverse colostomy (control group, n=35)
Number of subjects: 70
Study: 26962712

Group type: EXPERIMENTAL
Intervention: Catheter inserted at the sciatic nerve bifurcation
Number of subjects: 128

Group type: COMPARATOR
Intervention: Catheter inserted 5 cm proximal to the bifurcation
Number of subjects: 128
Study: 23506308

Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (20 U)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study: 21803324

Group type: EXPERIMENTAL
Intervention: Acellular glycerol‐cryopreserved corneal tissue (GCCT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Fresh corneal tissue (FCT)
Number of subjects: 64
Study: 19397474

Group type: EXPERIMENTAL
Intervention: low sodium + 100mg losartan + 25 mg hydrochlorothiazide
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study: 17142656

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg·kg-1 po administered 20-30 min preoperatively
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 30
Study: 15304970

Group type: EXPERIMENTAL
Intervention: 8 Gy external gamma‐irradiation
Number of subjects: 18
Study: 11737034

Group type: EXPERIMENTAL
Intervention: Presence of pets (dogs)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Presence of pets (cats)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Presence of vermin (cockroaches)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Homes without pets or vermin
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Homes with pets or vermin
Number of subjects: 454
Study: 8617997

Group type: EXPERIMENTAL
Intervention: 1 alpha,25(OH)2D3 (15 microgram/g Vaseline)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1958442

Group type: EXPERIMENTAL
Intervention: Slow release nicotinic acid formulation (500 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Rapid-release nicotinic acid formulation (500 mg)
Number of subjects: 7
Study: 7082061

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) device with intravenous morphine sulfate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard intramuscular dosages of morphine sulfate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Patient satisfaction with analgesia
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Morphine usage in PCA group
Number of subjects: 24
Study: 31310239

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 223
Study: 28652142

Group type: EXPERIMENTAL
Intervention: 5% KNO3 dentifrice (Test 1)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: 0.454% SnF2 dentifrice (Test 2)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Control dentifrices (6 negative controls)
Number of subjects: 249
Study: 26106009

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18201

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18201
Study: 23689309

Group type: EXPERIMENTAL
Intervention: Percutaneous sacroplasty (PSP)
Number of subjects: 58
Study: 22002109

Group type: EXPERIMENTAL
Intervention: Moderate-intensity cycling and treadmill walking exercises with a home program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 52
Study: 19563061

Group type: EXPERIMENTAL
Intervention: Yasmin (30 microg ethinylestradiol plus 3 mg drospirenone)
Number of subjects: 768

Group type: COMPARATOR
Intervention: Desogestrel (30 microg ethinylestradiol plus 150 microg desogestrel)
Number of subjects: 768
Study: 17563211

Group type: EXPERIMENTAL
Intervention: Contingent incentives for BCO reductions
Number of subjects: 37

Group type: COMPARATOR
Intervention: Noncontingent incentives
Number of subjects: 37
Study: 15373886

Group type: EXPERIMENTAL
Intervention: Attendance by infectious disease specialists (IDS) in ward 1
Number of subjects: 402

Group type: COMPARATOR
Intervention: Physicians from other specialties in ward 2
Number of subjects: 402
Study: 11605110

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine hydrochloride at the trocar site
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no local anesthesia)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Treatment group (local anesthesia)
Number of subjects: 100
Study: 11907935

Group type: COMPARATOR
Intervention: Conpremin (0.625 mg tablets)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Generic conjugated estrogens (0.625 mg tablets)
Number of subjects: 16
Study: 7862712

Group type: EXPERIMENTAL
Intervention: 40 mg cocaine IV on day 1, 25 mg cocaine IV on day 2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion on day 1, saline infusion on day 2
Number of subjects: 0
Study: 2117066

Group type: EXPERIMENTAL
Intervention: hCG (5000 I.U.) and alcohol
Number of subjects: 10

Group type: COMPARATOR
Intervention: hCG (5000 I.U.) and placebo
Number of subjects: 10
Study: 353652

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo machine
Number of subjects: 93
Study: 31832992

Group type: EXPERIMENTAL
Intervention: Buccal infiltration (BI) using 4% articaine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Inferior dental block (IDB) using 2% lidocaine
Number of subjects: 26
Study: 31161344

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 3
Study: 27386811

Group type: EXPERIMENTAL
Intervention: Water-based aerobic exercises (WB)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Land-based aerobic exercises (LB)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 133
Study: 25901093

Group type: EXPERIMENTAL
Intervention: Rapid decline in eGFR (Q1)
Number of subjects: 6083

Group type: COMPARATOR
Intervention: Stable eGFR (Q3)
Number of subjects: 6083

Group type: EXPERIMENTAL
Intervention: Rapid increase in eGFR (Q4)
Number of subjects: 6083
Study: 23481531

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 10101

Group type: COMPARATOR
Intervention: Diabetes mellitus
Number of subjects: 10101
Study: 20957631

Group type: EXPERIMENTAL
Intervention: HPV testing using clinician-collected samples
Number of subjects: 2670

Group type: EXPERIMENTAL
Intervention: Cervical cytology
Number of subjects: 2670

Group type: EXPERIMENTAL
Intervention: HPV testing using self-collected samples
Number of subjects: 2670
Study: 19161543

Group type: EXPERIMENTAL
Intervention: Micronutrient Sprinkles
Number of subjects: 96
Study: 18033629

Group type: EXPERIMENTAL
Intervention: Daily 10 mg alendronate and calcium
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Every other day 10 mg alendronate and calcium
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Daily 200 IU calcitonin and calcium
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (femoral neck)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Comparison of groups
Number of subjects: 46
Study: 15222889

Group type: EXPERIMENTAL
Intervention: Prize draw incentive (entry to win a personal digital assistant)
Number of subjects: 1410

Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 1410
Study: 11322350

Group type: EXPERIMENTAL
Intervention: Extended-release oxybutynin, 10 mg/d
Number of subjects: 332

Group type: COMPARATOR
Intervention: Tolterodine, 2 mg twice daily
Number of subjects: 332
Study: 9408932

Group type: EXPERIMENTAL
Intervention: Hydrotherapy treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Land treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60

Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 60
Study: 8233330

Group type: EXPERIMENTAL
Intervention: 4-millimeter incision
Number of subjects: 116

Group type: COMPARATOR
Intervention: 6-millimeter incision
Number of subjects: 116

Group type: COMPARATOR
Intervention: 11-millimeter incision
Number of subjects: 116

Group type: COMPARATOR
Intervention: Nuclear expression group
Number of subjects: 116
Study: 2878746

Group type: EXPERIMENTAL
Intervention: Somatostatin (4.1 micrograms/min for 120 min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oxytocin (0.4 micrograms/min for 120 min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Insulin (0.1 IU/kg body weight)
Number of subjects: 14
Study: 31240998

Group type: EXPERIMENTAL
Intervention: Computerized WCST administration
Number of subjects: 85

Group type: COMPARATOR
Intervention: Manual WCST administration
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Manual and Computerized WCST administration
Number of subjects: 85
Study: 30142838

Group type: EXPERIMENTAL
Intervention: sucrose+MLE
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: maltose+MLE
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: maltodextrin+MLE
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: glucose+MLE
Number of subjects: 15

Group type: COMPARATOR
Intervention: glucose
Number of subjects: 15
Study: 27633823

Group type: EXPERIMENTAL
Intervention: ePROM questionnaire completed monthly
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard paper PROM format
Number of subjects: 211
Study: 25077452

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Sham acupuncture (SA)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 67
Study: 22739049

Group type: EXPERIMENTAL
Intervention: Stochastic‐resonance mechanical vibration
Number of subjects: 29

Group type: COMPARATOR
Intervention: No vibration (control)
Number of subjects: 29
Study: 18930226

Group type: EXPERIMENTAL
Intervention: Gonadotropins in the follicular phase (group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: GnRH antagonists and recombinant FSH in the luteal phase (group II)
Number of subjects: 40
Study: 17573794

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG) 3350, 17 g daily for 28 days
Number of subjects: 237

Group type: COMPARATOR
Intervention: Tegaserod, 6 mg b.i.d. for 28 days
Number of subjects: 237
Study: 15546268

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Caffeine (control)
Number of subjects: 16
Study: 11343813

Group type: EXPERIMENTAL
Intervention: 75 mg diclofenac sodium i.m.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 9705188

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 0
Study: 8047518

Group type: EXPERIMENTAL
Intervention: Hospital-based group offered free flu shots
Number of subjects: 1989

Group type: EXPERIMENTAL
Intervention: Physician-based group offered free flu shots
Number of subjects: 1989

Group type: COMPARATOR
Intervention: Control group not offered free immunizations
Number of subjects: 1989
Study: 2522746

Group type: EXPERIMENTAL
Intervention: Epidural injection of 10 ml of autologous blood
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (10 ml)
Number of subjects: 100
Study: 6195761

Group type: EXPERIMENTAL
Intervention: Cefuroxime and Cefotaxim (antibiotic prophylaxis)
Number of subjects: 300

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (control group)
Number of subjects: 300
Study: 31984873

Group type: EXPERIMENTAL
Intervention: Media literacy intervention with counter argument production
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Media literacy intervention with counter story production
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 0
Study: 30229999

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (<10 ng/mL)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Vitamin D sufficiency (>20 ng/mL)
Number of subjects: 180
Study: 28512725

Group type: EXPERIMENTAL
Intervention: Clofibrate (50 mg/kg single dose prior to phototherapy)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care (only phototherapy)
Number of subjects: 90
Study: 26068230

Group type: EXPERIMENTAL
Intervention: Behavioral activation for diabetic retinopathy prevention
Number of subjects: 206

Group type: COMPARATOR
Intervention: Supportive therapy (control)
Number of subjects: 206
Study: 24411083

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg/d
Number of subjects: 917

Group type: COMPARATOR
Intervention: Finasteride 1 mg/d
Number of subjects: 917

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 917
Study: 21894450

Group type: EXPERIMENTAL
Intervention: Vibration training at 20 Hz with an amplitude of 2-4 mm for 2 × 5 min/day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control intervention without vibration
Number of subjects: 8
Study: 20042867

Group type: EXPERIMENTAL
Intervention: 14 days on sick leave wearing a neck collar
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Part-time sick leave and work adjustments
Number of subjects: 2

Group type: COMPARATOR
Intervention: No neck collar or sick leave
Number of subjects: 2

Group type: COMPARATOR
Intervention: Full-time sick leave
Number of subjects: 2
Study: 17701375

Group type: EXPERIMENTAL
Intervention: Bilateral pudendal nerve block with 0.25 percent bupivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine technique in use in the Department of Anesthesia (Control)
Number of subjects: 100
Study: 15839466

Group type: EXPERIMENTAL
Intervention: Optimised formulation of mefloquine (Mephaquin Lactabs/Test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 0
Study: 12495804

Group type: EXPERIMENTAL
Intervention: 1 mg buprenorphine
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: 3 mg buprenorphine
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: 8 mg buprenorphine
Number of subjects: 513
Study: 9650332

Group type: EXPERIMENTAL
Intervention: Percutaneous mitral valvotomy (PMV) in Group I (20 patients)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Percutaneous mitral valvotomy (PMV) in Group II (7 patients)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Follow-up after PMV in patients with previous MC
Number of subjects: 27
Study: 8091360

Group type: COMPARATOR
Intervention: 40 mg per day of lisinopril
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Combination of 20 mg of lisinopril and 12.5 mg of hydrochlorothiazide per day
Number of subjects: 68
Study: 2535973

Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 73903

Group type: EXPERIMENTAL
Intervention: Effervescent activated charcoal (10 g packet containing 5 g activated charcoal) administered 30 min after 75 mg nortriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple doses of effervescent activated charcoal
Number of subjects: 0
Study: 31277053

Group type: EXPERIMENTAL
Intervention: GLP-1 at 1.2 pmol/kg/min
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 192
Study: 29062346

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5mg/kg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 39
Study: 25810066

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN, 60 mg single dose, day 5) with cortisol (200 mg per day, days 1-6)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cortisol (200 mg per day, days 1-6) with placebo (single dose, day 5)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN)
Number of subjects: 8
Study: 24044618

Group type: EXPERIMENTAL
Intervention: Fasting calorie restriction (FCR) - reduction of 300-500 kcal/d combined with 2 days/week of Muslim Sunnah Fasting
Number of subjects: 0
Study: 21670611

Group type: EXPERIMENTAL
Intervention: Intraperitoneal local anesthetic (IPLA) - ropivacaine 75 mg instillation before dissection and 0.2% solution at 4 mL/hour for 3 days postoperative infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo - 0.9% saline solution instillation and infusion
Number of subjects: 60
Study: 19553646

Group type: EXPERIMENTAL
Intervention: Routine early PCI within 6 hours after fibrinolysis
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Standard treatment (including rescue PCI or delayed angiography)
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: Routine early PCI
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 1059
Study: 17394009

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 18 weeks (2 days/week)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Aerobic Training (AER) for 18 weeks (2 days/week)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Brachial artery flow mediated dilation (FMD)
Number of subjects: 23
Study: 16113435

Group type: EXPERIMENTAL
Intervention: Corticosteroid/beta(2)‐agonist combination therapy
Number of subjects: 0
Study: 11201519

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no HRT)
Number of subjects: 24
Study: 9881552

Group type: EXPERIMENTAL
Intervention: 500 mg oral ciprofloxacin eight hours before surgery
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 5 drops of 0.3% ciprofloxacin applied every twenty minutes starting 100 minutes before surgery
Number of subjects: 46
Study: 7770137

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA) with midazolam and alfentanil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional inhalation anaesthesia
Number of subjects: 40
Study: 2457006

Group type: EXPERIMENTAL
Intervention: 4 cycles of ABVD chemotherapy
Number of subjects: 157

Group type: COMPARATOR
Intervention: 2 cycles of MOPP + 2 cycles of ABVD chemotherapy
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Irradiation at a low dose (20 Gy) for good responders
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Mediastinal boost (up to 40 Gy) for poor responders
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Disease-free survival rate
Number of subjects: 157
Study: 31642426

Group type: EXPERIMENTAL
Intervention: Double filtration plasmapheresis (DFPP) combined with methylprednisolone (MP) and cyclophosphamide (CTX) pulse therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methylprednisolone (MP) and cyclophosphamide (CTX) pulse therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 28639097

Group type: EXPERIMENTAL
Intervention: 8-week Internet-based tailored exercise program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 25032943

Group type: COMPARATOR
Intervention: 8% glucose hyperbaric SAS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.8% glucose hyperbaric SAS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.5% glucose hyperbaric SAS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.33% glucose hyperbaric SAS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 23766446

Group type: EXPERIMENTAL
Intervention: Tailored low-salt diet
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard low-salt advice
Number of subjects: 56
Study: 21373801

Group type: EXPERIMENTAL
Intervention: Large femoral head metal-on-metal (MM) total hip arthroplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: 28-mm metal-on-polyethylene (MP) total hip arthroplasty
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (MM and MP)
Number of subjects: 50